Join StocksJar.com -Get 7 Days Free trial

Cognizant (CTSH) Stock Price & AI Analysis

NASDAQ
USA

$81.14

-$0.42
(-1.92%)

Subscribe to get
AI Score

  • Market Cap 40.44B
  • Volume 2.66M
  • Avg Volume 3.18M
  • Target Price $76.64
  • 52W Range 63.79 - 82.41
  • RSI (14) 59.69
  • Beta 1.06
  • PEG Ratio 2.69
  • SMA 20 1.49
  • SMA 50 4.30
  • SMA 200 10.55
  • Insider Owner 0.21%
  • Insider Trans -1.11%
  • Institution Owner 96.72%
  • Institution Trans -2.06%
  • Short Interest 16.09%
  • EPS next Y 6.97

Cognizant Company Profile

Cognizant Technology Solutions Corp. engages in providing information technology, consulting, and business process outsourcing services. Its services include application services, artificial intelligence, business process services, cloud solutions, and core modernization. It operates through the following segments: Financial Services (FS), Healthcare Sciences (HS), Products and Resources (P and R), and Communications, Media, and Technology (CMT). The FS segment focuses on banking and insurance services. The HS segment is involved in healthcare and life sciences. The P and R segment includes retail and consumer goods. The CMT segment relates to communications, information, media and entertainment, and technology. The company was founded by Wijeyaraj Kumar Mahadeva and Francisco D’Souza on April 6, 1988 and is headquartered in Teaneck, NJ.
Cognizant Technology Solutions Corp. engages in providing information technology, consulting, and business process outsourcing services. Its services include application services, artificial intelligence, business process services, cloud solutions, and core modernization. It operates through the following segments: Financial Services (FS), Healthcare Sciences (HS), Products and Resources (P and R), and Communications, Media, and Technology (CMT). The FS segment focuses on banking and insurance services. The HS segment is involved in healthcare and life sciences. The P and R segment includes retail and consumer goods. The CMT segment relates to communications, information, media and entertainment, and technology. The company was founded by Wijeyaraj Kumar Mahadeva and Francisco D’Souza on April 6, 1988 and is headquartered in Teaneck, NJ.

Cognizant | Latest news

Is Cognizant Technology Solutions Corporation's (NASDAQ:CTSH) Latest Stock...

Is Cognizant Technology Solutions Corporation's (NASDAQ:CTSH) Latest Stock...

Cognizant Technology Solutions' (NASDAQ:CTSH) stock is up by 7.0% over the past three months. Given...

Simply Wall St - 1 day ago

CTSH vs. WIT: Which Stock Is the Better Value Option?

CTSH vs. WIT: Which Stock Is the Better Value Option?

Investors with an interest in Business - Software Services stocks have likely encountered both...

Zacks - 4 days ago

Freedom Investment Management Inc. Decreases Stake in Cognizant Technology...

Freedom Investment Management Inc. Decreases Stake in Cognizant Technology...

Freedom Investment Management Inc. decreased its holdings in shares of Cognizant Technology Solutions Co. (NASDAQ:CTSH – Free Report) by 16.8% in the third quarter, according to its most recent ...

ETF DAILY NEWS - 6 days ago

Cognizant Technology Solutions Corp (CTSH) to Present at Nasdaq

Cognizant Technology Solutions Corp (CTSH) to Present at Nasdaq

Cognizant Technology Solutions Corp (CTSH, Financial), a prominent provider of IT, consulting, and business process services, announced its participation in the upcoming Nasdaq Investor Conference ...

Guru Focus - 4 days ago

Guidewire's Q1 Earnings and Revenues Top Estimates, Increase Y/Y

Guidewire's Q1 Earnings and Revenues Top Estimates, Increase Y/Y

GWRE's fiscal first-quarter performance benefits from higher subscription and support revenues.

Zacks - 2 days ago

Microchip Cuts Guidance Amid Restructuring, Shares Fall

Microchip Cuts Guidance Amid Restructuring, Shares Fall

Audioeye AEYE, Broadcom AVGO and Cognizant Technology Solutions CTSH are some better-ranked stocks...

Zacks - 5 days ago

NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class...

NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class...

Multi-Pathway Potential: By targeting both orexin receptors and Cathepsin H (CTSH) inhibition activity, AEX-41 offers a dual-action mechanism that could address not only sleep-wake regulation ...

Digital Journal - 5 days ago

Globant SA's SWOT analysis: IT services leader faces growth challenges By...

Globant SA's SWOT analysis: IT services leader faces growth challenges By...

Globant SA (NYSE:GLOB), a prominent player in the IT services sector with a market capitalization of...

Investingcom - 3 days ago